[1]郑庆厚,朱鲜阳.卵圆孔未闭的诊断与治疗[J].介入放射学杂志,2008,(07):527.
 ZHENG Qinghou,ZHU Xianyang.Diagnosis and treatment of patent foramen ovale[J].journal interventional radiology,2008,(07):527.
点击复制

卵圆孔未闭的诊断与治疗()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2008年07期
页码:
527
栏目:
综述
出版日期:
2008-07-15

文章信息/Info

Title:
Diagnosis and treatment of patent foramen ovale
作者:
郑庆厚朱鲜阳
110016沈阳军区总医院辽宁医学院研究生(郑庆厚);先心病内科(朱鲜阳)
Author(s):
ZHENG Qing-houZHU Xian-yang
Department of Congenial Cardiology,Affiliated General Hospital of Shenyang Military District,Liaoning Medical College,Shenyang110016,China
关键词:
卵圆孔未闭反常性栓塞治疗
分类号:
R541.1
文献标志码:
A
摘要:
卵圆孔未闭(patent foramen ovale,PFO)是一种特殊类型的房间隔交通,一般不引起有血液动力学意义的两心房间的分流,而无相关的临床症状和体征。但是,近年来的研究发现,PFO的存在与反常性栓塞、脑卒中、偏头痛等疾病的发生密切相关;当存在房间隔膨出瘤伴发PFO时也是脑梗死的危险因素,因此是不可忽视的疾病,本文探讨PFO的发生、临床表现、诊断及其并发症防治。

参考文献/References:

[1]Serena J,Segura T,Perez-Ayuso MJ ,et al.The need to quantify right-to-left shunt in acute ischemic stroke:a case-control study[J].Stroke,1998,29:1322-1328.
[2]Lethen H,Flaschkampf FA,Schneider R,et al.Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack[J].Am J Cardiol,1997,80:1066.
[3]王胜强,秦永文.对卵圆孔未闭的再认识[J].国外医学心血管疾病分册,2004,3l :72-74.
[4]Carcagni A,Di Sciascio G.Echocardiography in patent foramen ovale[J].Ital Cardiol(Rame ),2006,7:516-522.
[5]Droste DW,Lakemeier S,Wichter T,et al.Optimizing the technique of contrast transcranial doppler ultrasound in the detection of right-to-left shunt [J].Stroke,2002,33:2211-2217.
[6]Schwarze J,Sander D,Kukla C,et al.Methodological parameters influence the detection of right-to-left shunts by contrast transcranial Doppler ultrasonography[J].Stroke,1999,30:1234-1239.
[7]Tallarico D,Chiavari PA,Mollo P,et al.Transesophageal echocardiography through nasal way as a guide to percutaneous closure of patent foramen ovale[J].Echocardiography,2006,23:790-794.
[8]Homma S,Sacco RL,Di Tullio MR,et al.Effect of medical treatment in stroke patients with patent foramen ovale:patent foramen ovale in cryptogenic stroke study[J].Circulation,2002,105:2625-2633.
[9]Lamy C,Giannesini C,Zuber M,et al.Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale:the PFO-ASA study.Atrial Septal Aneurysm[J].Stroke,2002,33:706-712.
[10]Meier B,Lock JE.Contemporary management of patent foramen ovale[J].Circulationn,2003,107:5-8.
[11]Meissner I,Khandheria BK,Heit JA,et al.Patent foramen ovale:Innocent or guilty?Evidence from a prospective population-based study[J].J Am Coll Cardiol,2006,47:440-447.
[12]Cabanes L,Mas J,Cohen A,et al.Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than55years of age.A study using transesophageal echocardiography[J].Stroke,1993,24:1865-1868.
[13]Mugge A,Daniel WG,Angermann C,et al.Atrial septal aneurysm in adult patients.A multicenter study using transthoracic and transesophageal echocardiography[J].Circulation,1995,91:2785-2791.
[14]Overell JR,Bone I,Lees KR,et al.Interatrial septal abnor-malities and stroke:A meta-analysis of case-control studies[J].Neurology,2000,55:1172-1177.
[15]Messe SR,Silverman IE,Kizer JR,et al.Practice parameter:Recurrent stroke with patent foramen ovale and atrial septal aneurysm report of the quality standards subcommittee of theAmerican Academy of Neurology[J].Neurology,2004,62:1042-1044.
[16]王广义,郭军,王峙峰,等.经导管封堵卵圆孔未闭预防脑的矛盾栓塞[J].中国循环杂志,2005,20:17-20.
[17]Schwerzmann M,Seiler C,Lipp E,et al.Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers[J].Ann Intern Med,2001,134:21-29.
[18]Horton SC,Bunch TJ.Patent foramen ovale and stroke[J].Mayo Clin Proc,2004,79:79-84.
[19]Mas JL,Arouizan C,Lamy C,et al.Recurrent cerebrovascular events associated with patent foramen ovale,atrial septal aneurysm,or both[J].N Engl J Med,2001,345:1740-1744.
[20]Dearani JA,Ugurlu BS,Danielson GK,et al.Surgical patent foramen ovale clo-sure for prevention of paradoxical embolism-related cerebrovascular ischemic events[J].Circulation,1999,100(Suppl II):Ⅱ171-Ⅱ172.
[21]Michael,De Giovanni JV.A prospective,multicenter,phase I clinical trial to evaluate the feasibility,efficacy,and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts[J].Circulation,2006,114:1962-1965.
[22]Alaeddini J,Feghali G,Jenkins S,et al.Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale[J].J Invasiv Cardiol,2006,18:365-369.
[23]Wertman B,Azarbal B,Riedl M,et al.Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure[J].J Am Coll Cardiol,2006,47:1226-1231.
[24]王广义.经导管房间隔缺损介入封堵术及并发症[J].介入放射学杂志,2005,14:112-114.
[25]Khairy P,O’ Donnell CP,Landzberg MJ.Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli a systematic review[J].Ann Intern Med,2003,139:753-760.
[26]Schuchlenz HW,Weihs W,Horner S,et al.The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events[J].Am J Med,2000,109:456.
[27]Homma S,Sacco RL.Patent foramen ovale and stroke[J].Circu-lation,2005,112:1063-1066.
[28]Tong DC,Becker KJ.Patent foramen ovale and recurrent stroke:closure is the best op tion[J].Stroke,2004,35:804-810.

备注/Memo

备注/Memo:
收稿日期:2007-09-19
更新日期/Last Update: 2008-07-15